SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-023900
Filing Date
2022-08-24
Accepted
2022-08-24 08:15:36
Documents
18
Period of Report
2022-08-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 71146
2 ex4-1.htm EX-4.1 116357
3 ex10-1.htm EX-10.1 384375
4 ex10-2.htm EX-10.2 277006
5 ex10-3.htm EX-10.3 64876
6 ex99-1.htm EX-99.1 17862
7 ex99-1_001.jpg GRAPHIC 3247
  Complete submission text file 0001493152-22-023900.txt   1274362

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE xtnt-20220823.xsd EX-101.SCH 3239
9 XBRL LABEL FILE xtnt-20220823_lab.xml EX-101.LAB 34916
10 XBRL PRESENTATION FILE xtnt-20220823_pre.xml EX-101.PRE 22797
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3664
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 221188806
SIC: 2836 Biological Products, (No Diagnostic Substances)